NewAmsterdam Pharma Company N.V. (NAMS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -30.6M | -40.88M | -32.77M | -37.67M | -36.47M | -37.48M | -12.5M | -53.98M | -54.6M | -33.07M | -29.3M | 29.19M | -239.9K | -172.6K | -393.68K | 591.13K | -153.91K | -373.14K | -202.46K | -1.49M |
| Operating CF Margin % | -1006.71% | -127734.38% | -9416.38% | -196.77% | -1224.58% | -293.46% | -42.95% | -2368.54% | -3897.36% | -4118.8% | -1706.76% | 530.23% | -4.36% | -0.35% | -0.76% | - | - | - | - | - |
| Operating CF Growth % | 16.08% | -9.06% | -162.11% | 30.21% | 33.21% | -13.32% | - | -84.2% | - | -213.32% | -16878.46% | 4837.6% | -55.87% | 53.74% | -94.45% | 139.61% | 89.69% | 75% | 86.44% | - |
| Net Income | -48.44M | -74.92M | 39.53M | 0 | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -49.49M | -38.29M | -40.45M | -4.78M | -1.17M | 1.38M | 929.7K | 1.73M | -1.3M | 2.82M | -1.44M |
| Depreciation & Amortization | 62K | 59K | 64K | 45K | 52K | 51K | 28K | 19K | 15K | 13K | 13K | -14.74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250 |
| Stock-Based Compensation | 0 | 0 | 15.01M | 15.18M | 15.21M | 9.41M | 0 | 8.29M | 7.92M | 6.01M | 5.56M | 1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 13.68M | 29.42M | -77.02M | -29.05M | -22.56M | 53.21M | 4.09M | -8.7M | 41.37M | 1.06M | 423K | 9.15M | 2.49M | -817.9K | -1.73M | -384.28K | -2.1M | 994.05K | -3.06M | 76.5K |
| Working Capital Changes | 4.1M | 4.57M | -10.35M | -23.84M | 10.35M | -7.98M | 28K | -14.59M | -10.14M | 9.34M | 2.99M | 58.6M | 2.05M | 1.82M | -49.06K | 45.7K | 215.32K | -67.9K | 34.78K | -132K |
| Change in Receivables | 15.22M | -10.06M | 0 | 0 | 0 | 0 | -493K | -9.23M | 0 | 0 | 0 | 61.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -793K | 5.32M | -2.27M | -391K | 2.25M | -3.2M | 1.91M | -3.35M | -8.31M | 12.89M | 4.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -11.51M | -21.14M | 2.51M | -159.14M | 2.85M | -62.18M | -75K | -209K | -385K | -3K | -5K | -109.43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.25K |
| Capital Expenditures | -38K | -100K | -42K | -88K | -16K | -3K | -75K | -209K | -385K | -3K | -5K | -109.43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.25K |
| CapEx % of Revenue | 1.25% | 312.5% | 12.07% | 0.46% | 0.54% | 0.02% | 0.26% | 9.17% | 27.48% | 0.37% | 0.29% | 1.99% | 0% | 0% | 0% | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -62.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.25K |
| Cash from Financing | 11.06M | 13.68M | 5.89M | 3.42M | 6.52M | 456.61M | 58K | 4.66M | 198.18M | 0 | 6.33M | 153.39M | 0 | 0 | -45K | 0 | 0 | 0 | 0 | 2.84M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 11.06M | 13.68M | 5.89M | 3.42M | 0 | 456.61M | 58K | 4.66M | 190.48M | 0 | 0 | 0 | 0 | 0 | -45K | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 6.52M | 1.58M | 0 | 0 | 7.7M | 0 | 6.33M | 153.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.84M |
| Net Change in Cash | -32.38M | -48.39M | -24.15M | -184.56M | -23.32M | 349.01M | -7.98M | -50.44M | 140.7M | -27.86M | -24.61M | 0 | -239.9K | -172.6K | -438.68K | 591.13K | -153.91K | -373.14K | -202.46K | 1.34M |
| Free Cash Flow | -30.64M | -40.98M | -32.81M | -37.76M | -36.48M | -37.48M | -12.58M | -54.19M | -54.99M | -33.08M | -29.31M | 29.08M | -239.89K | -172.6K | -393.68K | 591.12K | -153.91K | -373.14K | -202.46K | -1.5M |
| FCF Margin % | -1007.96% | -128046.88% | -9428.45% | -197.23% | -1225.12% | -293.49% | -43.2% | -2377.71% | -3924.84% | -4119.18% | -1707.05% | 528.24% | -4.36% | -0.35% | -0.76% | - | - | - | - | - |
| FCF Growth % | 16.01% | -9.31% | -160.88% | 30.32% | 33.65% | -13.32% | - | -84.88% | - | -213.75% | -16881.46% | 4819.13% | -55.86% | 53.74% | -94.45% | 139.52% | 89.71% | 75.05% | 86.46% | - |
| FCF per Share | -0.25 | -0.36 | -0.28 | -0.34 | -0.31 | -0.39 | -0.13 | -0.57 | -0.67 | -0.40 | -0.36 | 1.58 | -0.01 | -0.01 | -0.02 | 0.03 | -0.01 | -0.02 | -0.01 | -0.08 |
| FCF Conversion (FCF/Net Income) | 0.63x | 0.55x | 0.46x | 2.17x | 0.92x | 0.41x | 0.75x | 1.38x | 0.58x | 0.67x | 0.77x | -0.77x | 0.01x | -0.01x | -0.01x | -0.03x | 0.01x | 0.07x | 0.04x | -36.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 138.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |